Selective unresponsiveness to HBsAg vaccine in newborns related with an in utero passage of hepatitis B virus DNA

By Lazizi Y.   Badur S.   Perk Y.   Ilter O.   Pillot J.  

Vaccine, Vol. 15, Iss. 10, 1997-07 ,pp. : 1095-1100

Elsevier

Access to resources Recommend Favorite

Selective unresponsiveness to HBsAg vaccine in newborns related with an in utero passage of hepatitis B virus DNA

By Lazizi Y.   Badur S.   Perk Y.   Ilter O.   Pillot J.  

Vaccine, Vol. 16, Iss. 16, 1998-10 ,pp. : 1593-1593

Elsevier

Access to resources Recommend Favorite

Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice

By Zheng B.-J.   Ng M.-H.   He L.-F.   Yao X.   Chan K.-W.   Yuen K.-Y.   Wen Y.-M.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4219-4225

Elsevier

Access to resources Recommend Favorite

Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine

By Koike Y.   Yoo Y.C.   Mitobe M.   Oka T.   Okuma K.   Tono-oka S.   Azuma I.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1982-1989

Elsevier

Access to resources Recommend Favorite

Weak immunogenicity of the preS2 sequence and lack of circumventing effect on the unresponsiveness to the hepatitis B virus vaccine

By Elias A.   Brancer M.   Budkowska A.   Pillot J.   Poynard T.   Maillard J.   Lazizi Y.   Dubreuil P.   Chaput J.C.  

Vaccine, Vol. 13, Iss. 3, 1995-01 ,pp. : 289-294

Elsevier

Access to resources Recommend Favorite